Related Experiment Video
Updated: Dec 6, 2025
10:57
Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
24.2K
Insights
Measuring US children
Area of Science:
- Pediatric health outcomes and disparities.
- Public health policy and child welfare.
Background:
- In 2020, nearly all US children possessed health insurance, yet many relied on government assistance for essential health and nutritional needs.
- Significant disparities in opportunities for child development persist across racial and ethnic lines.
- US children face substantial challenges, including high incidences of diagnosed behavioral health disorders and obesity.
Purpose of the Study:
- To assess the overall health status of children in the United States.
- To identify key factors influencing child health and well-being.
- To highlight areas requiring targeted interventions for improved pediatric health outcomes.
Main Methods:
- Analysis of national health insurance coverage data for children in 2020.
- Examination of government aid utilization for child health and nutrition.
- Review of prevalence data for behavioral health disorders, obesity, and opioid-related harms among US children.
Main Results:
- While health insurance is nearly universal, reliance on government aid indicates underlying socioeconomic challenges.
- Unequal distribution of opportunities for flourishing across racial and ethnic groups is a critical concern.
- High rates of diagnosed behavioral health disorders and obesity, alongside rising opioid use, represent significant threats to child health.
Conclusions:
- Despite widespread health insurance, US children's health is impacted by socioeconomic disparities and specific health challenges.
- Addressing behavioral health, obesity, and the effects of opioid use is crucial for improving pediatric health.
- Policy interventions are needed to ensure equitable opportunities for all children to thrive.
Abstract:
How do we measure the health of US children? In 2020 almost all US children have health insurance, but many are dependent on government aid for their health and nutrition. Opportunity to flourish is not distributed equally across racial and ethnic groups. US children have high rates of diagnosed behavioral health disorders and obesity. Rising rates of opioid use also pose harms to US children.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
139
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
139
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
107
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
107
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
160
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
160
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
130
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
130
01:30Preventive Healthcare Services
1.7K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.7K
01:29Drug Dosing: Infants and Children
134
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
134